Duarte (1)

Malignant Brain Neoplasm (1)

Recurrent Malignant Brain Neoplasm (1)

Refractory Malignant Brain Neoplasm (1)

Recruiting (1)

phase 1 (1)

City of Hope Medical Center (1)

National Cancer Institute (NCI) (1)

cyclophosphamide (1)

fludarabine (1)

il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes (1)

biological (1)

drug (1)

Other (1)

Interventional (1)

refractory malignant brain neoplasm

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

May 19, 2022